NDA 16717, held by Baxter Hlthcare. Invert Sugar.
As of Nov 13, 2026, NDA 16717 (Travert 10% In Plastic Container), held by Baxter Hlthcare, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Travert 10% In Plastic Container10GM/100ML ยท injectable;injection | Invert Sugar | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
